Elevance Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1998
Net Income	5,987	5,894	6,158	4,572	4,807	Upgrade
Depreciation & Amortization	1,745	1,675	1,302	1,154	1,133	Upgrade
Share-Based Compensation	289	264	255	283	294	Upgrade
Other Operating Activities	40	566	649	4,679	-173	Upgrade
Operating Cash Flow	8,061	8,399	8,364	10,688	6,061	Upgrade
Operating Cash Flow Growth	-4.02%	0.42%	-21.74%	76.34%	58.37%	Upgrade
Capital Expenditures	-1,296	-1,152	-1,087	-1,021	-1,077	Upgrade
Acquisitions	-1,552	-649	-3,476	-1,976	0	Upgrade
Change in Investments	-2,700	-2,338	-4,056	-3,433	-1,919	Upgrade
Other Investing Activities	-24	-421	-1,019	-894	204	Upgrade
Investing Cash Flow	-5,572	-4,560	-9,638	-7,324	-2,792	Upgrade
Dividends Paid	-1,395	-1,229	-1,104	-954	-818	Upgrade
Share Issuance / Repurchase	-2,524	-2,134	-1,697	-2,524	-1,514	Upgrade
Debt Issued / Paid	739	1,795	2,343	188	608	Upgrade
Other Financing Activities	-169	250	881	723	-542	Upgrade
Financing Cash Flow	-3,349	-1,318	423	-2,567	-2,266	Upgrade
Exchange Rate Effect	-1	-14	-10	7	0	Upgrade
Net Cash Flow	-861	2,507	-861	804	1,003	Upgrade
Free Cash Flow	6,765	7,247	7,277	9,667	4,984	Upgrade
Free Cash Flow Growth	-6.65%	-0.41%	-24.72%	93.96%	90.30%	Upgrade
Free Cash Flow Margin	3.95%	4.63%	5.25%	7.93%	4.78%	Upgrade
Free Cash Flow Per Share	28.79	30.34	29.98	38.87	19.66	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).